These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2323185)

  • 1. Purification of C8 and C9 from rat serum.
    Jones J; Laffafian I; Morgan BP
    Complement Inflamm; 1990; 7(1):42-51. PubMed ID: 2323185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of the eighth and ninth components of carp complement.
    Uemura T; Yano T; Shiraishi H; Nakao M
    Mol Immunol; 1996 Aug; 33(11-12):925-32. PubMed ID: 8960116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of late complement components by affinity chromatography: I. Purification of the human complement component C9 and production of a C9-defective human serum.
    Rauterberg EW; Schieck C; Hänsch G
    Z Immunitatsforsch Immunobiol; 1979 Jun; 155(5):365-77. PubMed ID: 112795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of six bovine complement components and one inactivator (1, 2).
    Barta O; Nelson RA; Kuo CY
    Immunol Commun; 1976; 5(1-2):75-86. PubMed ID: 950248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane attack complex proteins C5b-6, C7, C8, and C9 of human complement.
    Esser AF; Sodetz JM
    Methods Enzymol; 1988; 162():551-78. PubMed ID: 3226325
    [No Abstract]   [Full Text] [Related]  

  • 6. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.
    Hammer CH; Shin ML; Abramovitz AS; Mayer MM
    J Immunol; 1977 Jul; 119(1):1-8. PubMed ID: 559700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of the ninth component of rabbit complement.
    Hänsch GM; Rummel G; Gänzler F
    Complement; 1984; 1(2):116-22. PubMed ID: 6544183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restriction in the lytic efficiency of complement of different erythrocyte targets: a re-examination of the activities of horse C8 and C9.
    Yarnall DP; Boyle MD
    Mol Immunol; 1986 Aug; 23(8):823-9. PubMed ID: 3796626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of human and rat CD59 to the terminal complement complexes.
    Lehto T; Morgan BP; Meri S
    Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1984 Sep; 133(3):1453-63. PubMed ID: 6747293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinction between C8-mediated and C8/C9-mediated hemolysis on the basis of independent 86Rb and hemoglobin release.
    Gee AP; Boyle MD; Borsos T
    J Immunol; 1980 Apr; 124(4):1905-10. PubMed ID: 7365242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of the eighth component of the bovine complement system.
    Menger M; Sowery RD; Aston WP
    Am J Vet Res; 1999 Dec; 60(12):1474-7. PubMed ID: 10622154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoaffinity purification of human complement component C9 using monoclonal antibodies.
    Morgan BP; Daw RA; Siddle K; Luzio JP; Campbell AK
    J Immunol Methods; 1983 Nov; 64(3):269-81. PubMed ID: 6199425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ninth component of human complement: purification and physicochemical characterization.
    Biesecker G; Müller-Eberhard HJ
    J Immunol; 1980 Mar; 124(3):1291-6. PubMed ID: 6766971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Studies on C9 binding and incorporation into high molecular weight complexes.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Exp Med; 1986 Oct; 164(4):981-97. PubMed ID: 3760783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
    Stewart JL; Monahan JB; Brickner A; Sodetz JM
    Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.
    Schönermark S; Rauterberg EW; Shin ML; Löke S; Roelcke D; Hänsch GM
    J Immunol; 1986 Mar; 136(5):1772-6. PubMed ID: 2419413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number of hits necessary for complement-mediated hemolysis.
    Takeda J; Kozono H; Takata Y; Hong K; Kinoshita T; Sayama K; Tanaka E; Inoue K
    Microbiol Immunol; 1986; 30(5):461-8. PubMed ID: 3747864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA; Zhao J; Ninomiya H; Sims PJ
    J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER; Tschoop J; Müller-Eberhard HJ
    J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.